Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Edward Levine

Has grant

Wake Forest Baptist Medical Center

United States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in United States Professors in Cell Biology Cell Biology professors in United States

Recent Grants

Grant: Open

Interpretable Imaging-based Gastric Cancer, Prognosis via Prototypical and Attentional Deep Learning.

Open Date: 2025-04-01

Close Date: 2027-03-01

Grant: Close

NRG Cooperative group oncology trials.

Open Date: 2014-01-01

Close Date:

Grant: Close

PET IN MULTIMODALITY THERAPY FOR ESOPHAGEAL CANCER

Open Date: 2001-02-05

Close Date: 2004-01-31

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Collaborators (9)

Donna Niedzwiecki

Duke University

UNITED STATES

View details

Marcello Deraco

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

Peter H. Cashin

Researcher - Associate Professor

Uppsala University

SWEDEN

View details

Lance Miller

Professor

Wake Forest School of Medicine

UNITED STATES

View details

John H. Stewart

Chair of Surgery

Morehouse School of Medicine

UNITED STATES

View details

Ashok Pullikuth

Senior Investigator / Senior Staff Scientist

Wake Forest Baptist Medical Center

UNITED STATES

View details

Christina Fotopoulou

Consultant Gynae Oncology and Professor in Gynaecological Cancer Surgery

Imperial College London

UNITED KINGDOM

View details

Omeed Moaven

Assistant Professor

LSU Health Shreveport

UNITED STATES

View details

David Lawson Morris

Professor of Surgery

University of New South Wales

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Edward Levine

Research Interests

Make your next move.

Explore related searches

Recent Grants

Articles (20)

New Consensus Statements for Peritoneal Surface Malignancy

ASO Visual Abstract: MORPHology and Inter-Observer Variation in Peritoneal Disease Assessment Among Expert Peritoneal Malignancy SUrgeonS-The MORPHEUS Study

ASO Visual Abstract: Next-Generation Sequencing Identifies Key Targetable Mutations in the Treatment of Appendiceal Neoplasms

Does resection of cavity shave margins impact survival in breast cancer patients?

MORPHology and Inter-observer Variation in Peritoneal Disease Assessment Among Expert Peritoneal Malignancy SUrgeonS: The MORPHEUS study

MORPHology and Inter-observer Variation in Peritoneal Disease Assessment Among Expert Peritoneal Malignancy SUrgeonS: The MORPHEUS study (Mar, 10.1245/s10434-026-19344-3, 2026)

Mutational profiling of patient tumor organoids for clinical variable association and markers of therapeutic response in mucinous appendiceal cancers

Perioperative chemotherapy for clinical stage IIIB gallbladder cancer: a review of the National Cancer Database

Safety and feasibility of talimogene laherparepvec in peritoneal surface malignancies: Results from the TEMPO trial

Single-cell RNA sequencing reveals ancestry-associated molecular and cellular immunosuppressive features in non-small cell lung cancer.

Multisocietal Consensus on the Use of Cytoreductive Surgery and HIPEC for the Treatment of Diffuse Malignant Peritoneal Mesothelioma: A GRADE Approach for Evidence Evaluation and Recommendation

The Genomic Topography of Appendiceal Cancers: Our Current Understanding, Clinical Perspectives, and Future Directions

ASO Visual Abstract: Ten-Year Outcome of a Randomized Trial: Cytoreduction and HIPEC with Mitomycin C Versus Oxaliplatin for Appendiceal Neoplasm with Peritoneal Dissemination

Ten-Year Outcome of a Randomized Trial: Cytoreduction and HIPEC with Mitomycin C Versus Oxaliplatin for Appendiceal Neoplasm with Peritoneal Dissemination

ASO Author Reflections: Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) of Extraperitoneal Abdominal Disease, a Likely Common Practice but Infrequently Reported

ASO Visual Abstract: Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) of Extraperitoneal Abdominal Disease, Is it Appropriate?

Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) of Extraperitoneal Abdominal Disease, is it Appropriate?

Endocrine-targeting therapies shift the breast microbiome to reduce estrogen receptor-a breast cancer risk

Multisocietal Consensus on the Use of Cytoreductive Surgery and HIPEC for the Treatment of Epithelial Ovarian Cancer: A GRADE Approach for Evidence Evaluation and Recommendation

Guidelines for the Prophylaxis and Treatment of Peritoneal Metastases From Colorectal Cancer: A GRADE-Approach for Evidence Evaluation and Recommendations

Collaborators (9)

Donna Niedzwiecki

Marcello Deraco

Peter H. Cashin

Lance Miller

John H. Stewart

Ashok Pullikuth

Christina Fotopoulou

Omeed Moaven

David Lawson Morris

Make your next move.